Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study
BackgroundPatients with postmenopausal nonmetastatic estrogen receptor–positive breast cancer often experience a reduced quality of life after primary treatment. The disease and treatment trajectory consists of surgery followed by chemotherapy or radiation therapy. Upon this,...
Main Authors: | Trine Lund-Jacobsen, Peter Schwarz, Gabriella Martino, Helle Pappot, Karin Piil |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2024-02-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2024/1/e49549 |
Similar Items
-
A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
by: Mille Guldager Christiansen, et al.
Published: (2023-07-01) -
Research involvement and engagement of adolescent and young adults in a cancer trajectory: a 5-year experience from a patient support facility at a university hospital
by: Helle Pappot, et al.
Published: (2023-07-01) -
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
by: Pimpun Prasanchit, et al.
Published: (2024-03-01) -
Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review
by: Angeliki Andrikopoulou, et al.
Published: (2021-01-01) -
The Role of Aromatase Inhibitors in Male Prolactinoma
by: Amit Akirov, et al.
Published: (2023-02-01)